DIA Biosimilars 2014, September 18-19, Washington, DC

September 18 - 19, 2014 - Washington

With the expiration of numerous patents for originator biologicals and the development of follow-on products, the market for biosimilars is growing at a rapid pace. These biosimilars and follow-on biologics have garnered great interest for their cost-effective benefits in patient care as well as development opportunities for sponsors who see a new revenue stream. As biosimilars become more available to patients, there are important factors for patients and healthcare providers that must be addressed. This meeting will focus on the innovations, technologies, and regulatory information surrounding biosimilars.

More Information